UBS Group
BFRIW icon

UBS Group’s Biofrontera BFRIW Stock Holding History

UBS Group’s Portfolio BFRIW Stock Details BFRIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9 Sell
342
-1
-0.3% – ﹤0.01% 10332
2026
Q1 		$13 Hold
343
– – ﹤0.01% 10315
2025
Q4 		$31 Buy
+343
New +$32 ﹤0.01% 10314
2025
Q2 		– Sell
-891
Closed -$54 – 10258
2025
Q1 		$54 Sell
891
-1,628
-65% -$122 ﹤0.01% 10003
2024
Q4 		$154 Sell
2,519
-3,805
-60% -$258 ﹤0.01% 9597
2024
Q3 		$145 Buy
6,324
+6,314
+63,140% +$233 ﹤0.01% 9116
2024
Q2 		$0 Sell
10
-2,594
-100% -$133 ﹤0.01% 9524
2024
Q1 		$177 Buy
2,604
+2,394
+1,140% +$70 ﹤0.01% 8756
2023
Q4 		$2 Buy
210
+141
+204% +$4 ﹤0.01% 9187
2023
Q3 		$2 Buy
+69
New +$6 ﹤0.01% 9342
2023
Q1 		– Sell
-10
Closed -$2 – 9613
2022
Q4 		$2 Sell
10
-4,273
-100% -$1.73K ﹤0.01% 10644
2022
Q3 		$2K Buy
4,283
+430
+11% +$268 ﹤0.01% 9694
2022
Q2 		$3K Buy
+3,853
New +$4.25K ﹤0.01% 9284
2022
Q1 		– Sell
-2,750
Closed -$10K – 10257
2021
Q4 		$10K Buy
+2,750
New +$5.93K ﹤0.01% 8758

Other funds holding BFRIW

BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

UBS Group's BFRIW Position: Q2 2026 in Review

UBS Group reduced its Biofrontera (BFRIW) stake by 0.29% in Q2 2026, cutting 1 share and leaving 342 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #10332.

UBS Group first reported a position in BFRIW in Q4 2021 and has held it in 14 quarters since. The position peaked at $10K in Q4 2021. 5 funds tracked by Wall St. Rank hold BFRIW as of Q2 2026.

  • UBS Group held 342 shares of Biofrontera worth $9 as of Q2 2026.
  • UBS Group sold 1 Biofrontera share in Q2 2026.
  • Biofrontera made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10332 holding.
  • UBS Group first reported a position in Biofrontera in Q4 2021 and has held it in 14 quarters since.
  • UBS Group's Biofrontera position peaked at $10K in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Biofrontera as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.